MedPath

PMS-MOMETASONE

PMS-MOMETASONE

Approved
DIN Number

02244768

Drug Class

Human

Market Date

N/A

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244768
AIG Number0121732001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07AC13 MOMETASONE
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

MOMETASONE FUROATEActive
Strength: .1 %
Monograph: MOMETASONE FUROATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.